Abstract:Introduction In mental health prevention, person-centered, and rights-based approaches, the role of recovery is highlighted (WHO, 2021). Various evaluation tools are used in rehabilitation objectives and programs, including the Specific Levels of Functioning Scale (SLOF) (Mucci et al. Schizophr Res 2014;159 144-50) and the Recovery Assessment Scale – Domains and Stages (RAS-DS), a self-measure of mental health recovery. It includes 38 items clustered into four recovery domains and meets two functions. In addition to measuring self-reported outcomes, it increases service-user control towards objectives and recovery action plans (Honey et al. BMC Psychiatry 2023;23 500). Objectives To evalue the efficacy of RAD-DS in a psychiatric rehabilitation facility to be used as a routine tool in daily rehabilitation activity. Methods In our observational study, we recruited 103 inpatients (total: 103 patients, females: 38 patients, males: 65 patients) in a psychiatric rehabilitation facility. The patient presented with psychiatric disorders that met the diagnostic criteria of DMS-5 (schizophrenia, bipolar disorder, MDD, personality borderline disorder). Epidemiological data are shown in Table 1. All patients were undergoing a psychiatric rehabilitation program and were observed during a one-year evaluation. In all patients, the following rating scales were administered at baseline (T0) and after a year (T1): For the evaluation of social measures, life outcomes, and functioning and recovery: - Recovery Assessment Scale – Domains and Stages RAS-DS - Specific Levels of Functioning Scale (SLOF) - Global Assessment of Functioning (GAF) For psychopathological evaluation: - Brief Psychiatric Rating Scale (BPRS) The data were statistically analyzed with the EZAnalyze 3.0 software for the Excel platform. Results The RAS-DS total score results (Table 2) show a not significant difference between T0 vs. T1 (mean: 101.80 vs. 104.37, p. 0.193). An improvement in the score was observed after one year of rehabilitation treatment in the subgroup "Doing things I value" (T0 vs. T1: mean 16.15 vs. 18.77, p 0.001). Statistically significant differences were observed in the subgroups "Mastering my illness" (T0 vs. T1: mean 18.3 vs. 20.85, p. 0.021). In the other subgroups, the differences were not statistically significant. Interestingly, these results are comparable to those found with SLOF and GAF (respectively, p. 0.972 and p. 0.873). Image: Image 2: Conclusions The current trend of research and clinical practice is to give more importance to psychiatric rehabilitation treatment (Franza Psychiatr Danub 2022;34(Suppl 8) 9-13). The results obtained with our observational study indicate the possible usefulness of indicators of patient well-being, as well as the RAS-DS in the management of psychiatric rehabilitation programs. The expectations, indications, and perceptions of psychiatric patients can be decisive in improving recovery. Disclosure of Interest None Declared

Achieving functional remission in schizophrenia: a pilot study

Patients’ awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychotics

Design and validation of standardized clinical and functional remission criteria in schizophrenia

Neurocognitive functioning and emotional recognition in first-episode psychosis: protocol for a follow- up study

Symptom Remission and Brain Cortical Networks at First Clinical Presentation of Psychosis: the OPTiMiSE Study.

Stratification and prediction of remission in first-episode psychosis patients OPTIMISE

The Role of Depression in the Prediction of a “late” Remission in First-Episode Psychosis: an Analysis of the OPTiMiSE Study

Evaluation of the effectiveness of psychosocial treatment of patients with schizophrenia at different stages of its rendering

A Retrospective Real-Life Pilot Study

Functioning Management and Recovery, a psychoeducational intervention for psychiatric residential facilities: a multicenter follow-up study

Awareness and perceptions of managing recovery in psychiatric patients in a rehabilitation center: an observational study

Study protocol – elucidating the neural correlates of functional remediation for older adults with bipolar disorder

Investigation of cytokine imbalance in schizophrenia, assessment of the possible role of serum cytokine levels in predicting treatment response, prognosis and psychotic relapses

Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patients

Predictive Value of Prospective Memory for Remission in First-Episode Schizophrenia.

Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial

Long-Term Course of Remission and Recovery in Psychotic Disorders

Effectiveness of psychosocial treatments on symptoms and functional domains in schizophrenia spectrum disorders: a prospective study in a real-world setting

Metacognition, emotional dysregulation, psychosocial functioning and subjective well-being after 6 months of CBT treatment in pharmacologically stabilized schizophrenic patients

The comparison of plasma zonulin levels between symptom exacerbation and treatment response periods in schizophrenia: a case-control study with follow-up

Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: a randomized controlled trial